<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00259545</url>
  </required_header>
  <id_info>
    <org_study_id>PC2</org_study_id>
    <secondary_id>EC - L71/2003</secondary_id>
    <secondary_id>BFARM - 402 29 17</secondary_id>
    <nct_id>NCT00259545</nct_id>
  </id_info>
  <brief_title>Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis</brief_title>
  <official_title>Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Professor Wolfgang Stremmel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dietmar Hopp Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if retarded release phosphatidylcholine is an
      effective alternative to steroid dependent or -refractory course in chronic active ulcerative
      colitis.

      The hypothesis is, that ulcerative colitis is caused by a barrier defect of the colonic mucus
      layer. The background of the study is the finding, that the phosophatidylcholine content of
      the colonic mucus is strongly reduced in ulcerative colitis (UC) compared to healthy controls
      and patients with Crohn´s disease. The content was measured in non-inflamed areas of the
      colon in UC. Thus, we evaluate whether a substitution of colonic PC is an effective method
      for steroid dependent UC. See: Gut. 2005 Jul;54(7):966-71. Stremmel et al.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Prospective, randomized, placebo-controlled, double-blinded study.

      Population: 60 patients with chronic active ulcerative colitis and steroid dependency

      Inclusion: Chronic active ulcerative colitis, clinical index 5 or more, endoscopic Index 5 or
      more, steroid dependent course since at least 4 months.

      Main criteria: complete steroid reduction
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2003</start_date>
  <completion_date>February 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complete steroid reduction</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>remission, life quality, clinical indices, endoscopic indices, histological score, subgroup analysis</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Phosphatidylcholine</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Retarded Release Phosphatidylcholine (rPC)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed Letter of Content

          -  diagnosis of ulcerative colitis (clinical, endoscopic and histologic evidence)

          -  chronic active and steroid dependent course over at least 4 months (CAI &gt; 4, EAI &gt; 4)

        Exclusion Criteria:

          -  infectious colitis

          -  toxic megacolon

          -  ulcerative proctitis or less than 20cm inflamed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Stremmel, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Heidelberg - Medical Department 4 - Gastroenterology</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut. 2005 Jul;54(7):966-71.</citation>
    <PMID>15951544</PMID>
  </reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2005</study_first_submitted>
  <study_first_submitted_qc>November 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2005</study_first_posted>
  <last_update_submitted>June 4, 2008</last_update_submitted>
  <last_update_submitted_qc>June 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2008</last_update_posted>
  <keyword>retarded phosphatidylcholine</keyword>
  <keyword>chronic active</keyword>
  <keyword>steroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

